Exchange: NASDAQ·Updated 01:11 PM EDT
DMAC logo

DMAC DiaMedica Therapeutics Inc

$8.80
$0.08
(0.92%)
Today
EarningsNov 11
Mkt Cap$470.23M
Vol41,302.00

About DMAC

DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from serious ischemic diseases with a focus on preeclampsia, fetal growth restriction, and acute ischemic stroke. DiaMedica’s lead candidate DM199 is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treatment of acute ischemic stroke, preeclampsia and other vascular diseases.
46

Neutral Sentiment

How do you feel about DMAC?

JMforProfits
$DMAC DiaMedica will hold a key opinion leader (KOL) webinar on October 23 at 8:00 AM ET. The company will present preliminary interim results from the first six patients in its Phase 2 early-onset FGR trial.
4
Pegger
$DMAC moving up steadily with important updates on the horizon and not a peep of news being leaked out. Maybe just maybe 🤔
4
PumpnRun
$DMAC Awfully quiet around here and stock keeps going up. Never fails, when I sell they keep going up.
2

Advertisement|Remove ads.